119 related articles for article (PubMed ID: 23565522)
21. Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.
Popp AW; Isenegger J; Buergi EM; Buergi U; Lippuner K
Eur Spine J; 2006 Jul; 15(7):1035-49. PubMed ID: 16474946
[TBL] [Abstract][Full Text] [Related]
22. Anabolic steroids in corticosteroid-induced osteoporosis.
Adami S; Rossini M
Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
[TBL] [Abstract][Full Text] [Related]
23. Medication-induced osteoporosis.
Weng MY; Lane NE
Curr Osteoporos Rep; 2007 Dec; 5(4):139-45. PubMed ID: 18430387
[TBL] [Abstract][Full Text] [Related]
24. Clinical question: What is the best approach to managing glucocorticoid-induced osteoporosis?
Compston J
Clin Endocrinol (Oxf); 2011 May; 74(5):547-50. PubMed ID: 21470278
[TBL] [Abstract][Full Text] [Related]
25. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival.
Wang FS; Wu RW; Ko JY; Tai MH; Ke HC; Yeh DW; Wu SL; Chen MW
Bone; 2011 Nov; 49(5):1080-9. PubMed ID: 21854881
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid induced risk of fractures.
Maruotti N; Corrado A; Cantatore FP
Panminerva Med; 2010 Dec; 52(4):339-43. PubMed ID: 21183894
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced bone loss: a major safety concern in Europe.
Nguyen KD; Bagheri B; Bagheri H
Expert Opin Drug Saf; 2018 Oct; 17(10):1005-1014. PubMed ID: 30222369
[TBL] [Abstract][Full Text] [Related]
28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
29. [Pathogenesis, prevention and therapy of steroid osteoporosis].
Dambacher MA; Olah AJ; Maurer H; Gampp R; Rüegsegger P
Z Orthop Ihre Grenzgeb; 1990; 128(3):234-9. PubMed ID: 2144069
[TBL] [Abstract][Full Text] [Related]
30. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
31. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2006 Jun; 25(2):72-8. PubMed ID: 16908396
[TBL] [Abstract][Full Text] [Related]
32. [Glucocorticoid-induced osteoporosis: recent findings].
Angeli A; Osella G; Reimondo G; Terzolo M
Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
[TBL] [Abstract][Full Text] [Related]
33. Corticosteroid osteoporosis.
Sambrook P; Lane NE
Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):401-13. PubMed ID: 11485337
[TBL] [Abstract][Full Text] [Related]
34. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
Steiniche T
APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
[TBL] [Abstract][Full Text] [Related]
35. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
Xu D; Yang W; Zhou C; Liu Y; Xu B
Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
[TBL] [Abstract][Full Text] [Related]
36. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
van Staa TP
Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
[TBL] [Abstract][Full Text] [Related]
38. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
39. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced osteoporosis: prevention and treatment.
Ziegler R; Kasperk C
Steroids; 1998; 63(5-6):344-8. PubMed ID: 9618799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]